Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A novel 3'-tRNAGlu-derived fragment acts as a tumor suppressor in breast cancer by targeting nucleolin.
Falconi M, Giangrossi M, Zabaleta ME, Wang J, Gambini V, Tilio M, Bencardino D, Occhipinti S, Belletti B, Laudadio E, Galeazzi R, Marchini C, Amici A. Falconi M, et al. Among authors: occhipinti s. FASEB J. 2019 Dec;33(12):13228-13240. doi: 10.1096/fj.201900382RR. Epub 2019 Sep 27. FASEB J. 2019. PMID: 31560576
., Elexpuru Zabaleta, M., Wang, J., Gambini, V., Tilio, M., Bencardino, D., Occhipinti, S., Belletti, B., Laudadio, E., Galeazzi, R., Marchini, C., Amici, A. ...
., Elexpuru Zabaleta, M., Wang, J., Gambini, V., Tilio, M., Bencardino, D., Occhipinti, S., Belletti, B., Laudadio, E., Galeaz …
Chimeric rat/human HER2 efficiently circumvents HER2 tolerance in cancer patients.
Occhipinti S, Sponton L, Rolla S, Caorsi C, Novarino A, Donadio M, Bustreo S, Satolli MA, Pecchioni C, Marchini C, Amici A, Cavallo F, Cappello P, Pierobon D, Novelli F, Giovarelli M. Occhipinti S, et al. Clin Cancer Res. 2014 Jun 1;20(11):2910-21. doi: 10.1158/1078-0432.CCR-13-2663. Epub 2014 Mar 25. Clin Cancer Res. 2014. PMID: 24668647 Free article.
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer.
Bartolacci C, Andreani C, Curcio C, Occhipinti S, Massaccesi L, Giovarelli M, Galeazzi R, Iezzi M, Tilio M, Gambini V, Wang J, Marchini C, Amici A. Bartolacci C, et al. Among authors: occhipinti s. Cancer Immunol Res. 2018 Dec;6(12):1486-1498. doi: 10.1158/2326-6066.CIR-18-0179. Epub 2018 Oct 16. Cancer Immunol Res. 2018. PMID: 30327365
Erbb2 DNA vaccine combined with regulatory T cell deletion enhances antibody response and reveals latent low-avidity T cells: potential and limits of its therapeutic efficacy.
Rolla S, Ria F, Occhipinti S, Di Sante G, Iezzi M, Spadaro M, Nicolò C, Ambrosino E, Merighi IF, Musiani P, Forni G, Cavallo F. Rolla S, et al. Among authors: occhipinti s. J Immunol. 2010 Jun 1;184(11):6124-32. doi: 10.4049/jimmunol.0901215. Epub 2010 Apr 30. J Immunol. 2010. PMID: 20435927
B7h triggering inhibits the migration of tumor cell lines.
Dianzani C, Minelli R, Gigliotti CL, Occhipinti S, Giovarelli M, Conti L, Boggio E, Shivakumar Y, Baldanzi G, Malacarne V, Orilieri E, Cappellano G, Fantozzi R, Sblattero D, Yagi J, Rojo JM, Chiocchetti A, Dianzani U. Dianzani C, et al. Among authors: occhipinti s. J Immunol. 2014 May 15;192(10):4921-31. doi: 10.4049/jimmunol.1300587. Epub 2014 Apr 11. J Immunol. 2014. PMID: 24729612 Free article.
Regulation of Langerhans cell functions in a hypoxic environment.
Pierobon D, Raggi F, Cambieri I, Pelassa S, Occhipinti S, Cappello P, Novelli F, Musso T, Eva A, Castagnoli C, Varesio L, Giovarelli M, Bosco MC. Pierobon D, et al. Among authors: occhipinti s. J Mol Med (Berl). 2016 Aug;94(8):943-55. doi: 10.1007/s00109-016-1400-9. Epub 2016 Mar 10. J Mol Med (Berl). 2016. PMID: 26960761 Free article.
Low Levels of Urinary PSA Better Identify Prostate Cancer Patients.
Occhipinti S, Mengozzi G, Oderda M, Zitella A, Molinaro L, Novelli F, Giovarelli M, Gontero P. Occhipinti S, et al. Cancers (Basel). 2021 Jul 16;13(14):3570. doi: 10.3390/cancers13143570. Cancers (Basel). 2021. PMID: 34298784 Free PMC article.
136 results